324 related articles for article (PubMed ID: 35750138)
1. Soluble TREM2 levels reflect the recruitment and expansion of TREM2
Hendrikx T; Porsch F; Kiss MG; Rajcic D; Papac-Miličević N; Hoebinger C; Goederle L; Hladik A; Shaw LE; Horstmann H; Knapp S; Derdak S; Bilban M; Heintz L; Krawczyk M; Paternostro R; Trauner M; Farlik M; Wolf D; Binder CJ
J Hepatol; 2022 Nov; 77(5):1373-1385. PubMed ID: 35750138
[TBL] [Abstract][Full Text] [Related]
2. CD44 is a key player in non-alcoholic steatohepatitis.
Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
[TBL] [Abstract][Full Text] [Related]
3. TREM2 Regulates the Removal of Apoptotic Cells and Inflammatory Processes during the Progression of NAFLD.
Liebold I; Meyer S; Heine M; Kuhl A; Witt J; Eissing L; Fischer AW; Koop AC; Kluwe J; Wiesch JSZ; Wehmeyer M; Knippschild U; Scheja L; Heeren J; Bosurgi L; Worthmann A
Cells; 2023 Jan; 12(3):. PubMed ID: 36766683
[TBL] [Abstract][Full Text] [Related]
4. Dopamine receptor D2 antagonism normalizes profibrotic macrophage-endothelial crosstalk in non-alcoholic steatohepatitis.
Qing J; Ren Y; Zhang Y; Yan M; Zhang H; Wu D; Ma Y; Chen Y; Huang X; Wu Q; Mazhar M; Wang L; Liu J; Ding BS; Cao Z
J Hepatol; 2022 Feb; 76(2):394-406. PubMed ID: 34648896
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis.
Krenkel O; Puengel T; Govaere O; Abdallah AT; Mossanen JC; Kohlhepp M; Liepelt A; Lefebvre E; Luedde T; Hellerbrand C; Weiskirchen R; Longerich T; Costa IG; Anstee QM; Trautwein C; Tacke F
Hepatology; 2018 Apr; 67(4):1270-1283. PubMed ID: 28940700
[TBL] [Abstract][Full Text] [Related]
6. Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitis.
Krenkel O; Hundertmark J; Abdallah AT; Kohlhepp M; Puengel T; Roth T; Branco DPP; Mossanen JC; Luedde T; Trautwein C; Costa IG; Tacke F
Gut; 2020 Mar; 69(3):551-563. PubMed ID: 31076404
[TBL] [Abstract][Full Text] [Related]
7. Exercise of high intensity ameliorates hepatic inflammation and the progression of NASH.
Fredrickson G; Barrow F; Dietsche K; Parthiban P; Khan S; Robert S; Demirchian M; Rhoades H; Wang H; Adeyi O; Revelo XS
Mol Metab; 2021 Nov; 53():101270. PubMed ID: 34118476
[TBL] [Abstract][Full Text] [Related]
8. Modulating sphingosine 1-phosphate receptor signaling skews intrahepatic leukocytes and attenuates murine nonalcoholic steatohepatitis.
Liao CY; Barrow F; Venkatesan N; Nakao Y; Mauer AS; Fredrickson G; Song MJ; Sehrawat TS; Dasgupta D; Graham RP; Revelo XS; Malhi H
Front Immunol; 2023; 14():1130184. PubMed ID: 37153573
[TBL] [Abstract][Full Text] [Related]
9. Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis.
Morikawa R; Nakamoto N; Amiya T; Chu PS; Koda Y; Teratani T; Suzuki T; Kurebayashi Y; Ueno A; Taniki N; Miyamoto K; Yamaguchi A; Shiba S; Katayama T; Yoshida K; Takada Y; Ishihara R; Ebinuma H; Sakamoto M; Kanai T
J Hepatol; 2021 Mar; 74(3):511-521. PubMed ID: 33038434
[TBL] [Abstract][Full Text] [Related]
10. Myeloid Trem2 ameliorates the progression of metabolic dysfunction-associated steatotic liver disease by regulating macrophage pyroptosis and inflammation resolution.
Yu W; Zhang Y; Sun L; Huang W; Li X; Xia N; Chen X; Wikana LP; Xiao Y; Chen M; Han S; Wang Z; Pu L
Metabolism; 2024 Jun; 155():155911. PubMed ID: 38609037
[TBL] [Abstract][Full Text] [Related]
11. TREM2 protects against inflammation by regulating the release of mito-DAMPs from hepatocytes during liver fibrosis.
Shan S; Chao S; Liu Z; Wang S; Liu Z; Zhang C; Cheng D; Su Z; Song F
Free Radic Biol Med; 2024 Aug; 220():154-165. PubMed ID: 38710340
[TBL] [Abstract][Full Text] [Related]
12. Hepatic TREM2
Lee KJ; An S; Kim MY; Kim SM; Jeong WI; Ko HJ; Yang YM; Noh M; Han YH
Immunol Cell Biol; 2023 Mar; 101(3):216-230. PubMed ID: 36529983
[TBL] [Abstract][Full Text] [Related]
13. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder.
Hu J; Wang H; Li X; Liu Y; Mi Y; Kong H; Xi D; Yan W; Luo X; Ning Q; Wang X
Theranostics; 2020; 10(21):9702-9720. PubMed ID: 32863955
[No Abstract] [Full Text] [Related]
14. Hepatic danger signaling triggers TREM2
Zhou L; Qiu X; Meng Z; Liu T; Chen Z; Zhang P; Kuang H; Pan T; Lu Y; Qi L; Olson DP; Xu XZS; Chen YE; Li S; Lin JD
Sci Transl Med; 2024 Mar; 16(738):eadk1866. PubMed ID: 38478630
[TBL] [Abstract][Full Text] [Related]
15. RIP1 kinase activity promotes steatohepatitis through mediating cell death and inflammation in macrophages.
Tao L; Yi Y; Chen Y; Zhang H; Orning P; Lien E; Jie J; Zhang W; Xu Q; Li Y; Ding Z; Wu C; Ding Q; Wang J; Zhang J; Weng D
Cell Death Differ; 2021 Apr; 28(4):1418-1433. PubMed ID: 33208891
[TBL] [Abstract][Full Text] [Related]
16. Lipid-Associated Macrophages Control Metabolic Homeostasis in a Trem2-Dependent Manner.
Jaitin DA; Adlung L; Thaiss CA; Weiner A; Li B; Descamps H; Lundgren P; Bleriot C; Liu Z; Deczkowska A; Keren-Shaul H; David E; Zmora N; Eldar SM; Lubezky N; Shibolet O; Hill DA; Lazar MA; Colonna M; Ginhoux F; Shapiro H; Elinav E; Amit I
Cell; 2019 Jul; 178(3):686-698.e14. PubMed ID: 31257031
[TBL] [Abstract][Full Text] [Related]
17. Deficient chaperone-mediated autophagy in macrophage aggravates inflammation of nonalcoholic steatohepatitis by targeting Nup85.
Zhang M; Tian SY; Ma SY; Zhou X; Zheng XH; Li B; Guo GY; Yu JH; Su R; Yang FF; Hu YN; Ma G; Yang H; Zheng LH; Guo CC; Shang YL; Wang JB; Han Y
Liver Int; 2023 May; 43(5):1021-1034. PubMed ID: 36912786
[TBL] [Abstract][Full Text] [Related]
18. Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease.
Gwag T; Reddy Mooli RG; Li D; Lee S; Lee EY; Wang S
JHEP Rep; 2021 Feb; 3(1):100193. PubMed ID: 33294831
[TBL] [Abstract][Full Text] [Related]
19. Mapping the hepatic immune landscape identifies monocytic macrophages as key drivers of steatohepatitis and cholangiopathy progression.
Guillot A; Winkler M; Silva Afonso M; Aggarwal A; Lopez D; Berger H; Kohlhepp MS; Liu H; Özdirik B; Eschrich J; Ma J; Peiseler M; Heymann F; Pendem S; Mahadevan S; Gao B; Diehl L; Gupta R; Tacke F
Hepatology; 2023 Jul; 78(1):150-166. PubMed ID: 36630995
[TBL] [Abstract][Full Text] [Related]
20. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
